loadpatents
name:-0.0040340423583984
name:-0.0039989948272705
name:-0.087870121002197
Pairish; Mason Alan Patent Filings

Pairish; Mason Alan

Patent Applications and Registrations

Patent applications and USPTO patent grants for Pairish; Mason Alan.The latest application filed is for "pyrimidine derivatives".

Company Profile
0.12.16
  • Pairish; Mason Alan - San Diego CA
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Pyrimidine derivatives
Grant 9,758,538 - Chen , et al. September 12, 2
2017-09-12
Pyrimidine Derivatives
App 20170015689 - Chen; Ping ;   et al.
2017-01-19
Enantiomerically Pure Aminoheteroaryl Compounds As Protein Kinase Inhibitors
App 20140288086 - CUI; Jingrong Jean ;   et al.
2014-09-25
Enantiomerically pure aminoheteroaryl compounds as protein kinase inhibitors
Grant 8,785,632 - Cui , et al. July 22, 2
2014-07-22
4-methylpyridopyrimidinone compounds
Grant 8,633,204 - Cheng , et al. January 21, 2
2014-01-21
4-methylpyridopyrimidinone Compounds
App 20120309775 - CHENG; Hengmiao ;   et al.
2012-12-06
Enantiomerically Pure Aminoheteroaryl Compounds As Protein Kinase Inhibitors
App 20120263706 - Cui; Jingrong Jean ;   et al.
2012-10-18
4-methylpyridopyrimidinone compounds
Grant 8,273,755 - Cheng , et al. September 25, 2
2012-09-25
Aminoheteroaryl compounds as protein kinase inhibitors
Grant 8,106,197 - Cui , et al. January 31, 2
2012-01-31
Enantiomerically pure aminoheteroaryl compounds as protein kinase inhibitors
Grant 7,858,643 - Cui , et al. December 28, 2
2010-12-28
Enantiomerically Pure Aminoheteroaryl Compounds As Protein Kinase Inhibitors
App 20100324061 - Cui; Jingrong Jean ;   et al.
2010-12-23
Pyrazole compounds as RAF inhibitors
Grant 7,772,246 - Cui , et al. August 10, 2
2010-08-10
Triazolopyrazine derivatives
Grant 7,732,604 - Cheng , et al. June 8, 2
2010-06-08
4-methylpyridopyrimidinone Compounds
App 20100137279 - Cheng; Hengmiao ;   et al.
2010-06-03
Triazolopyrazine Derivatives
App 20100105656 - Cheng; Hengmiao ;   et al.
2010-04-29
4-methylpyridopyrimidinone compounds
Grant 7,696,213 - Cheng , et al. April 13, 2
2010-04-13
Pyrazole Compounds
App 20090221608 - Cui; Jingrong Jean ;   et al.
2009-09-03
4-methylpyridopyrimidinone Compounds
App 20080090801 - Cheng; Hengmiao ;   et al.
2008-04-17
Triazolopyrazine Derivatives
App 20070265272 - Cheng; Hengmiao ;   et al.
2007-11-15
Aminoheteroaryl compounds as protein kinase inhibitors
Grant 7,230,098 - Cui , et al. June 12, 2
2007-06-12
Aminoheteroaryl compounds as protein kinase inhibitors
App 20070072874 - Cui; Jingrong Jean ;   et al.
2007-03-29
Aminoheteroaryl compounds as protein kinase inhibitors
App 20060178374 - Cui; Jingrong Jean ;   et al.
2006-08-10
Pyrazole-substituted aminoheteroaryl compounds as protein kinase inhibitors
App 20060128724 - Cui; Jingrong Jean ;   et al.
2006-06-15
Enantiomerically pure aminoheteroaryl compounds as protein kinase inhibitors
App 20060046991 - Cui; Jingrong Jean ;   et al.
2006-03-02
Aminoheteroaryl compounds as protein kinase inhibitors
App 20050009840 - Cui, Jingrong Jean ;   et al.
2005-01-13

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed